These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2432780)

  • 1. Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors.
    Feldman JM; O'Dorisio TM
    Am J Med; 1986 Dec; 81(6B):41-8. PubMed ID: 2432780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors.
    Feldman JM
    Gastroenterology; 1978 Dec; 75(6):1109-14. PubMed ID: 309417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary serotonin in the diagnosis of carcinoid tumors.
    Feldman JM
    Clin Chem; 1986 May; 32(5):840-4. PubMed ID: 2421946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved diagnosis of carcinoid tumors by measurement of platelet serotonin.
    Kema IP; de Vries EG; Schellings AM; Postmus PE; Muskiet FA
    Clin Chem; 1992 Apr; 38(4):534-40. PubMed ID: 1373675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
    Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
    Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities.
    Lundin L; Norheim I; Landelius J; Oberg K; Theodorsson-Norheim E
    Circulation; 1988 Feb; 77(2):264-9. PubMed ID: 2448062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminating capacity of indole markers in the diagnosis of carcinoid tumors.
    Meijer WG; Kema IP; Volmer M; Willemse PH; de Vries EG
    Clin Chem; 2000 Oct; 46(10):1588-96. PubMed ID: 11017936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease.
    Carling RS; Degg TJ; Allen KR; Bax ND; Barth JH
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):577-82. PubMed ID: 12564839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P in the localization of a carcinoid tumor.
    Strodel WE; Vinik AI; Jaffe BM; Eckhauser FE; Thompson NW
    J Surg Oncol; 1984 Oct; 27(2):106-11. PubMed ID: 6207386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma substance-P in neuroendocrine tumors and idiopathic flushing: the value of pentagastrin stimulation tests and the effects of somatostatin analog.
    Vinik AI; Gonin J; England BG; Jackson T; McLeod MK; Cho K
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1702-9. PubMed ID: 1693375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motilin in plasma and tumor tissues from patients with the carcinoid syndrome. Possible involvement in the increased frequency of bowel movements.
    Oberg K; Theodorsson-Norheim E; Norheim I
    Scand J Gastroenterol; 1987 Nov; 22(9):1041-8. PubMed ID: 2447632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush.
    Norheim I; Theodorsson-Norheim E; Brodin E; Oberg K
    J Clin Endocrinol Metab; 1986 Sep; 63(3):605-12. PubMed ID: 2426299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection.
    Kema IP; Meijer WG; Meiborg G; Ooms B; Willemse PH; de Vries EG
    Clin Chem; 2001 Oct; 47(10):1811-20. PubMed ID: 11568091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioenzymatic assay of platelet serotonin, dopamine and norepinephrine in subjects with normal and increased serotonin production.
    Feldman JM; Davis JA
    Clin Chim Acta; 1981 Feb; 109(3):275-83. PubMed ID: 6164511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated concentrations of substance P and 5-HT in plasma in patients with carcinoid tumors.
    Emson PC; Gilbert RF; Martensson H; Nobin A
    Cancer; 1984 Aug; 54(4):715-8. PubMed ID: 6204735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature.
    Mao C; el Attar A; Domenico DR; Kim K; Howard JM
    Int J Pancreatol; 1998 Apr; 23(2):153-64. PubMed ID: 9629513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum peptide profiles in patients with carcinoid tumors.
    Calhoun K; Toth-Fejel S; Cheek J; Pommier R
    Am J Surg; 2003 Jul; 186(1):28-31. PubMed ID: 12842744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone and prolactin secretion in the carcinoid syndrome.
    Feldman JM; Plonk JW; Bivens CH; Lebovitz HE; Handwerger S
    Am J Med Sci; 1975; 269(3):333-47. PubMed ID: 125543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary free cortisol excretion in patients with hyperserotoninaemia from the carcinoid syndrome.
    Feldman JM
    Clin Endocrinol (Oxf); 1979 Nov; 11(5):541-8. PubMed ID: 316372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary carcinoid tumor of the bilateral testis associated with carcinoid syndrome.
    Son HY; Ra SW; Jeong JO; Koh EH; Lee HI; Koh JM; Kim WB; Park JY; Shong YK; Lee KU; Kim GS; Kim MS
    Int J Urol; 2004 Nov; 11(11):1041-3. PubMed ID: 15509216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.